Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
about
Translational biomarkers of neurotoxicity: a Health and Environmental Sciences Institute perspective on the way forwardBench-to-Bedside and Bedside Back to the Bench; Seeking a Better Understanding of the Acute Pathophysiological Process in Severe Traumatic Brain InjuryA review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injuryTraumatic white matter injury and glial activation: from basic science to clinics.Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhageUbiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizureBlood-based diagnostics of traumatic brain injuries.Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluidsHuman traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hitsSerum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest.Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study.Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBINeuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to "composite" blast.Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patientsSerum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Therapy development for diffuse axonal injury.Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord InjuryNeuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression modelNeuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats.A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.Addressing the needs of traumatic brain injury with clinical proteomics.Biomarkers in traumatic brain injury: a review.Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore.Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.Microdialysis as Clinical Evaluation of Therapeutic Hypothermia in Rat Subdural Hematoma Model.Citrate-capped gold nanoparticles for the label-free detection of ubiquitin C-terminal hydrolase-1.Do Low Serum UCH-L1 and TDP-43 Levels Indicate Disturbed Ubiquitin-Proteosome System in Autism Spectrum Disorder?Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats.UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic-Ischemic Encephalopathy: A Single Center Pilot Study.Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis.cPKCγ-mediated down-regulation of UCHL1 alleviates ischaemic neuronal injuries by decreasing autophagy via ERK-mTOR pathway.A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.
P2860
Q23920632-B5D95A7D-1685-4775-9930-8C238B4CE856Q26823369-BA3C556D-7AB4-4913-BC39-81E69984E7E4Q30448137-19D73410-9737-4373-B4FE-71804046B2CDQ30816308-C58F6270-6F26-4341-82B4-EB8DE2735928Q33916315-3ED3F485-86FB-443C-8636-7DB6FACE3F32Q34103510-13073EC0-9C79-4CFA-82B9-DFC8C2CF96CFQ34397124-EA049DE9-5135-4327-BE65-6CBF58490AD1Q34714369-E18870C6-F13A-4A0B-AD92-E88186A8D442Q35040539-2ECB4EE1-1A4C-44FB-B1B8-04E3AFEA3BABQ35131093-EC17433B-AC03-430F-B723-1A33BE164359Q35164692-74483EE7-A103-470A-92FF-8A9CA2920184Q35224118-0F856F24-7A60-4391-8E8E-1C91FB2961F2Q35570888-EE6AB3A0-5C71-4DEA-AA0B-13298DBD31AFQ35659358-4B2E48BA-5B1A-42B6-B9C0-57AF4DA622C8Q35745771-46CE371F-007D-4DE6-805E-9C4E3467098AQ35783757-3E13B747-5EEE-4B7C-8AC4-60E6294A3A57Q35876807-A0B93495-EF6A-4A87-B8F0-280BE8B913AAQ36079583-F295113B-4945-42A9-AF55-49686A5FE0DEQ36131599-755FD1E8-0A1A-4458-AA5D-2EE6CB332321Q36768885-3A35F17E-605D-4376-BFD2-4A21BD9DAFE6Q36796090-62855192-B38D-40E0-A479-399A6A597802Q37061236-889EA9AB-AA26-4EB2-89F5-85D86E3C75DAQ37076892-59AE6C9E-F133-4E53-A9A3-A6EA58DF73E9Q37141680-EFD38487-67E4-4E05-8702-6D0882928C5DQ37428030-A3B7A758-8927-4795-A95D-00B5E4685DF9Q37590627-2D9FB8BD-1F9C-4BDE-BC13-E46972A3F29AQ37685775-58914141-4E83-4A74-A88D-81FD4D565063Q38623128-35C994D7-1A93-4CAE-8EF6-B119C547DAE1Q38629921-00F18D9B-8208-4B6B-ACB7-6FAADF7736FAQ38644674-BE0C5080-4246-4B11-83A7-E7DFCB89916FQ39257016-3DDB2584-4B85-47B4-89F0-86FB8ED61D1AQ39413053-BB7A0B1E-6891-48A1-B1F0-C00DF29D90ADQ41679939-5147CD79-BBC4-47B2-9D86-61FAC4E0690EQ42371373-C9C3EFD7-B3E2-4AF5-B0C4-6108A8CB6015Q42716996-D9B0311F-7596-4E0F-AB6F-B440E1F7398EQ43072831-22DBC570-3998-48D1-8F9C-4AE022C72760Q44923505-672F2029-3CB4-4B30-8B91-8C8E79E06175Q46156813-07EE4EE6-AAD3-4230-A177-D57EB3BDAEB0Q47130601-7CD1B29B-0D1A-4B3B-AB8C-C7BF7640AEA7Q47250022-C46487C0-D482-43DE-9D22-49F98DD5675A
P2860
Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@ast
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@en
type
label
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@ast
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@en
prefLabel
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@ast
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@en
P2093
P2860
P1476
Ubiquitin C-terminal hydrolase ...... raumatic brain injury in rats.
@en
P2093
Dancia Scharf
Frank C Tortella
Jitendra R Dave
Jixiang Mo
Linda Papa
Linnet Akinyi
Ming C Liu
Monika W Oli
Ronald L Hayes
Stephen F Larner
P2860
P304
P356
10.1111/J.1460-9568.2010.07097.X
P407
P577
2010-02-01T00:00:00Z